{"id":4256,"date":"2022-09-12T13:27:31","date_gmt":"2022-09-12T11:27:31","guid":{"rendered":"https:\/\/www.mc-praha.cz\/mcp\/?p=4256"},"modified":"2022-09-12T13:28:13","modified_gmt":"2022-09-12T11:28:13","slug":"aktualni-informace-o-modifikovanych-bivalentnich-vakcinach-proti-onemocneni-covid-19","status":"publish","type":"post","link":"https:\/\/www.mc-praha.cz\/mcp\/aktualni-informace-o-modifikovanych-bivalentnich-vakcinach-proti-onemocneni-covid-19\/","title":{"rendered":"Aktu\u00e1ln\u00ed informace o modifikovan\u00fdch bivalentn\u00edch vakc\u00edn\u00e1ch proti onemocn\u011bn\u00ed COVID-19"},"content":{"rendered":"<p>Evropsk\u00e1 komise vydala na z\u00e1klad\u011b doporu\u010den\u00ed Evropsk\u00e9 agentury pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky (EMA) rozhodnut\u00ed o registraci vakc\u00edn Comirnaty Original\/Omicron BA.1 a Spikevax Bivalent Original\/Omicron BA.1. Jedn\u00e1 se o verze vakc\u00edn proti onemocn\u011bn\u00ed COVID-19 od spole\u010dnost\u00ed Pfizer\/BioNTech a Moderna upraven\u00e9 tak, aby krom\u011b p\u016fvodn\u00edho kmenu viru SARS-CoV-2 c\u00edlily i na subvariantu omikron BA.1. Jsou schv\u00e1len\u00e9 jen jako posiluj\u00edc\u00ed 3. a 4. d\u00e1vky (boostery) navazuj\u00edc\u00ed na z\u00e1kladn\u00ed sch\u00e9ma o\u010dkov\u00e1n\u00ed.<\/p>\n<p>Ji\u017e v\u00a0\u010dervenci 2022 St\u00e1tn\u00ed zdravotn\u00ed \u00fastav informoval, \u017ee BA.1 (p\u016fvodn\u00ed kmen varianty omikron) je v\u00a0\u010cR na \u00fastupu, dominuj\u00ed varianty BA.4 a BA.5 a objevuj\u00ed se st\u00e1le nov\u00e9. P\u0159esto\u017ee v\u00a0populaci tak koluje ji\u017e \u0159ada dal\u0161\u00edch subvariant omikronu, podle v\u011bdc\u016f by nyn\u00ed registrovan\u00e9 vakc\u00edny m\u011bly obst\u00e1t i proti nim. V brzk\u00e9 dob\u011b by se nab\u00eddka schv\u00e1len\u00fdch modifikovan\u00fdch vakc\u00edn m\u011bla v\u00a0EU roz\u0161\u00ed\u0159it i o vakc\u00edny proti subvariant\u00e1m BA.4\/BA.5.<\/p>\n<p>Vakc\u00ednu Comirnaty Original\/Omicron BA.1 i Spikevax Bivalent Original\/Omicron BA.1 lze pou\u017e\u00edt u dosp\u011bl\u00fdch a dosp\u00edvaj\u00edc\u00edch ve v\u011bku od 12 let, nejd\u0159\u00edve 3 m\u011bs\u00edce po z\u00e1kladn\u00edm o\u010dkov\u00e1n\u00ed nebo posilovac\u00ed d\u00e1vce vakc\u00ednou proti COVID-19. Ob\u011b tyto tzv. bivalentn\u00ed vakc\u00edny jsou v\u00a0\u010cR dostupn\u00e9 od 8. z\u00e1\u0159\u00ed 2022.<\/p>\n<p>Dle d\u0159\u00edv\u011bj\u0161\u00edho sd\u011blen\u00ed \u010cesk\u00e9 vakcinologick\u00e9 spole\u010dnosti je v\u00a0r\u00e1mci posiluj\u00edc\u00edch d\u00e1vek mo\u017en\u00e9 zvolit jin\u00fd typ RNA vakc\u00edny, nap\u0159\u00edklad po dvoj\u00ed aplikaci Comirnaty je mo\u017eno p\u0159eo\u010dkovat vakc\u00ednou Moderna\/Spikevax a naopak.<\/p>\n<p>Z\u00e1rove\u0148 V\u00fdbor pro hum\u00e1nn\u00ed l\u00e9\u010div\u00e9 p\u0159\u00edpravky (CHMP) agentury EMA doporu\u010dil pou\u017eit\u00ed vakc\u00edny Nuvaxovid (Novavax) jako posiluj\u00edc\u00ed d\u00e1vky pro\u00a0dosp\u011bl\u00e9, kte\u0159\u00ed dostali Nuvaxovid \u010di jinou vakc\u00ednu proti COVID-19 v r\u00e1mci z\u00e1kladn\u00edho sch\u00e9matu o\u010dkov\u00e1n\u00ed.<\/p>\n<p>P\u016fvodn\u00ed o\u010dkovac\u00ed l\u00e1tky Comirnaty a Moderna\/Spikevax se budou nad\u00e1le pou\u017e\u00edvat pro z\u00e1kladn\u00ed sch\u00e9ma o\u010dkov\u00e1n\u00ed (1. a 2. d\u00e1vky).<\/p>\n<p>8.9. 2022<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Evropsk\u00e1 komise vydala na z\u00e1klad\u011b doporu\u010den\u00ed Evropsk\u00e9 agentury pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky (EMA) rozhodnut\u00ed o registraci [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"image","meta":{"_uag_custom_page_level_css":""},"categories":[1],"tags":[],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"boldthemes_grid":false,"boldthemes_grid_11":false,"boldthemes_grid_22":false,"boldthemes_grid_21":false,"boldthemes_grid_12":false,"boldthemes_latest_posts":false,"boldthemes_grid_gallery":false},"uagb_author_info":{"display_name":"Ane\u017eka Klubalov\u00e1","author_link":"https:\/\/www.mc-praha.cz\/mcp\/author\/aklubalova\/"},"uagb_comment_info":0,"uagb_excerpt":"Evropsk\u00e1 komise vydala na z\u00e1klad\u011b doporu\u010den\u00ed Evropsk\u00e9 agentury pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky (EMA) rozhodnut\u00ed o registraci [&hellip;]","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/posts\/4256"}],"collection":[{"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/comments?post=4256"}],"version-history":[{"count":1,"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/posts\/4256\/revisions"}],"predecessor-version":[{"id":4258,"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/posts\/4256\/revisions\/4258"}],"wp:attachment":[{"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/media?parent=4256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/categories?post=4256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mc-praha.cz\/mcp\/wp-json\/wp\/v2\/tags?post=4256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}